Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: SFRP1 increases TMPRSS2-ERG expression promoting neoplastic features in prostate cancer in vitro and in vivo

Fig. 3

Effects of SFRP1 on cell viability and cell cycle. Cells were treated with DHT (0.01 nM) and SFRP1 (0.01 nM). Cell viability was measured by MTT assay and cell cycle was determined by flow cytometry with IP. a LNCaP cells, *p ≤ 0.01 vs vehicle (ad). Effects of SFRP1 on cell viability in PC3 and RWPE-1 cells (ef). In the cytometry assays, LNCaP, PC3 and RWPE-1 cells were treated for 48 h, and VCaP for 72 h. Nocodazole was used as G2 arrester at 1 μM

Back to article page